Importantly, PMN-MDSCs and, to a lesser extent, M-MDSCs isolated from the blood of prostate cancer patients show high surface levels of LIF receptor and respond to LIF stimulation with STAT3 activation and increased T-cell inhibition. The gene discussed is STAT3; the disease is prostate cancer.